title: Cyclosporin in less common immune-mediated skin diseases.
abstract: Cyclosporin represents a major step forward in the systemic treatment of various dermatoses. Psoriasis vulgaris and atopic eczema, the two major indications for the drug, are dealt with elsewhere in this issue. Therefore, this short review will focus on less common inflammatory skin diseases.
authors.affiliation: Department of Dermatology, Heinrich-Heine University, Dusseldorf, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Ruzicka
mesh_terms: D001528:Behcet Syndrome / Q000188:drug therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents; D016572:Cyclosporine